NMDA receptor antibodies: A rare association in inflammatory demyelinating diseases

Neurology: Neuroimmunology and NeuroInflammation

Volumn 2, Issue 5, 2015, Pages e141-

  Ramberger, Melanie ^a   Bsteh, Gabriel ^a   Schanda, Kathrin ^a   Hoftberger, Romana ^b   Rostasy, Kevin ^a,c   Baumann, Matthias ^a   Djamshidian, Fahmy Aboulenein ^d   Lutterotti, Andreas ^a,e   Deisenhammer, Florian ^a   Berger, Thomas ^a   Reindl, Markus ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c UNIVERSITY OF WITTEN HERDECKE   (Germany)

^d DANUBE HOSPITAL   (Austria)

^e UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AQUAPORIN 4 ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR ANTIBODY;

ACUTE DISSEMINATED ENCEPHALOMYELITIS; ADOLESCENT; ADULT; AGED; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; CASE CONTROL STUDY; CHILD; CONTROLLED STUDY; DEMYELINATING DISEASE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MENTAL DISEASE; MULTIPLE SCLEROSIS; MYELOOPTIC NEUROPATHY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEIZURE; SEROPREVALENCE;

EID: 84969773479     PISSN: None     EISSN: 23327812     Source Type: Journal    
DOI: 10.1212/NXI.0000000000000141     Document Type: Article

References (10)

1. Dalmau J, Lancaster E, Martinez-Hernandez E, Rosenfeld MR, Balice-Gordon R. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neu-rol 2011;10:63-74.
2. Hacohen Y, Absoud M, Woodhall M, et al. Autoantibody biomarkers in childhood-acquired demyelinating syndromes: results from a national surveillance cohort. J Neurol Neurosurg Psychiatry 2014;85:456-461.
3. Kruer MC, Koch TK, Bourdette DN, et al. NMDA receptor encephalitis mimicking seronegative neuromyelitis op-tica. Neurology 2010;74:1473-1475.
4. Fleischmann R, Pruss H, Rosche B, et al. Severe cognitive impairment associated with intrathecal antibodies to the NR1 subunit of the N-methyl-D-aspartate receptor in a patient with multiple sclerosis. JAMA Neurol 2015;72: 96-99.
5. Titulaer MJ, Hoftberger R, Iizuka T, et al. Overlapping demyelinating syndromes and anti-N-methyl-D-aspartate receptor encephalitis. Ann Neurol 2014;75:411-428.
6. Ramberger M, Peschl P, Schanda K, et al. Comparison of diagnostic accuracy of microscopy and flow cytometry in evaluating N-methyl-d-aspartate receptor antibodies in serum using a live cell-based assay. PLoS One 2015;10: e0122037.
7. Mader S, Gredler V, Schanda K, et al. Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders. J Neuroinflammation 2011;8:184.
8. Baumann M, Sahin K, Lechner C, et al. Clinical and neuroradiological differences of paediatric acute disseminating encephalomyelitis with and without antibodies to the myelin oligodendrocyte glycoprotein. J Neurol Neuro-surg Psychiatry 2015;86:265-272.
9. Gresa-Arribas N, Titulaer MJ, Torrents A, et al. Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study. Lancet Neurol 2014;13:167-177.
10. Dahm L, Ott C, Steiner J, et al. Seroprevalence of auto-antibodies against brain antigens in health and disease. Ann Neurol 2014;76:82-94.